 |
|
|
|
|
|
|
The following is a list of tradeshows we will be attending. We look
forward to seeing you there. If you have any questions regarding TRELSTAR or any
of the listed events please fill out our
request form and we will have someone contact you.
2008 Tradeshow schedule*:
|
|
| February |
| 2/28–3/2 |
Marriott Waterside
Tampa, FL |
Society Urologic Nurses Association -SPRING |
|
| March |
| 3/6–3/9 |
Manchester Grand Hyatt
San Diego, CA |
AUA Southeastern Sectional Meeting |
|
| May |
| 5/17–5/22 |
Orange County Convention Center
Orlando, FL |
American Urological Association |
|
| September |
| 9/17–9/21 |
Hyatt Regency
Santa Ana Pueblo, NM |
AUA North Eastern Sectional Meeting |
| 9/18–9/21 |
Grand Hyatt Manchester
San Diego, CA |
AUA South Central Sectional Meeting |
| 9/24–9/27 |
Hyatt Regency
Chicago, IL |
AUA North Central Sectional Meeting |
| 9/24–9/28 |
Westin Rio Mar Hotel
Rio Grande, Puerto Rico |
AUA New England Sectional Meeting |
| 9/25–9/28 |
Cambridge, MD |
AUA Mid-Atlantic Sectional Meeting |
|
| October |
| 10/3–10/6 |
Marriott Hotel
Philadelphia, PA |
Society Urologic Nurses Association -FALL |
| 10/26–10/30 |
Portola Plaza Hotel
Monterey, CA |
AUA Western Sectional Meeting |
|
Watson is committed to providing the professional community with current,
relevant, and valuable disease-state information related to prostate treatment.
We are dedicated to supporting educational programs and initiatives that advance
the treatment of urological diseases.
To receive an invitation or be notified when CME programs become available, click
here.
* Events subject to change without notice.
|
|
|
|
|
Indications and Usage
TRELSTAR® Depot and TRELSTAR®
LA are indicated in the palliative treatment of advanced prostate cancer. TRELSTAR
Depot or TRELSTAR LA offer an alternative treatment for prostate cancer when orchiectomy
or estrogen administration are either not indicated or unacceptable to the patient. |
|
|
|
Safety Information
|
|
The most commonly reported adverse events associated with the use of TRELSTAR®
Depot/TRELSTAR® LA included hot flushes (58.6%/73.0%), skeletal pain
(12.1%/13.2%), impotence (7.1%/2.3%), headache (5.0%/6.9%), leg pain (2.1%/5.2%),
and edema in legs (0.0%/6.3%) . TRELSTAR is contraindicated in women who are or
may become pregnant as well as patients who are hypersensitive to triptorelin, other
LHRH agonists, or LHRH . Infrequent postmarketing reports of anaphylactic shock
and angioedema have been received since 1986 (global experience) . As with all LHRH
agonists, triptorelin causes an initial transient increase in testosterone levels.
Patients may experience the onset or exacerbation of symptoms during this period,
including bone pain, neuropathy, hematuria, spinal cord compression, or urethral
or bladder outlet obstruction. Patients with metastatic vertebral lesions and/or
urinary tract obstruction should be closely observed. |
|
|
|
|
|
|
|
|
|
